Omics in schizophrenia: current progress and future directions of antipsychotic treatments

Omics in schizophrenia: current progress and future directions of antipsychotic treatments

Abstract. Schizophrenia is a life-long, complex mental illness that still lacks satisfactory treatments. In recent years, increasing numbers of candidate biomarkers of schizophrenia occurrences and drug responses to schizophrenia therapies have been successfully identified by many omics studies. Thi...

Full description

Bibliographic Details
Main Authors:	Yidan Sun, Wei Zhou, Luan Chen, Cong Huai, Hailiang Huang, Lin He, Shengying Qin
Format:	Article
Language:	English
Published:	Wolters Kluwer Health 2019-12-01
Series:	Journal of Bio-X Research
Online Access:	http://journals.lww.com/10.1097/JBR.0000000000000049

Similar Items

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
by: Lally J, et al.
Published: (2016-11-01)

Self in schizophrenia: Current issues and future directions
by: Chandril Chandan Ghosh, et al.
Published: (2018-01-01)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
by: Correll Christoph, et al.
Published: (2005-05-01)

Antipsychotics and risk of natural death in patients with schizophrenia
by: Chen Y, et al.
Published: (2019-07-01)

New atypical antipsychotics for schizophrenia: iloperidone
by: Silvio Caccia, et al.
Published: (2010-02-01)

ADHERENCE TO ANTIPSYCHOTIC MEDICATION IN SCHIZOPHRENIA PATIENTS
by: Peter Pregelj
Published: (2009-01-01)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
by: Correll Christoph U, et al.
Published: (2008-04-01)

Antipsychotic agents: efficacy and safety in schizophrenia
by: de Ara&uacute;jo AN, et al.
Published: (2012-11-01)

Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia
by: Haishan Wu, et al.
Published: (2013-01-01)

Antipsychotics Persistence of Patients with Schizophrenia in Taiwan
by: Chia-ChengLai, et al.
Published: (2010)

Adherence of the discharged schizophrenias to the antipsychotic medications
by: ZENG,WEN-QI, et al.
Published: (1990)

Utilization of Antipsychotic Agents in Patients with Schizophrenia
by: Chia-Wei Hung, et al.

Adult Patients with Schizophrenia and Noncompliance with Antipsychotics
by: Arceo, Jan Michael, et al.
Published: (2018)

Antipsychotic drugs and sexual function in schizophrenia
by: Mahmoud, Ahmed Mohamed
Published: (2008)

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients
by: Wei Zhou, et al.
Published: (2019-03-01)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
by: Sang Won Jeon, et al.
Published: (2017-10-01)

OMICS: Current and future perspectives in reproductive medicine and technology
by: Rocío Rivera Egea, et al.
Published: (2014-01-01)

Thalamic shape abnormalities in antipsychotic naïve schizophrenia
by: Vijay Danivas, et al.
Published: (2013-01-01)

Entorhinal cortex volume in antipsychotic-naïve schizophrenia
by: Sam P Jose, et al.
Published: (2012-01-01)

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-05-01)

The therapeutic relationship and adherence to antipsychotic medication in schizophrenia.
by: Rosemarie McCabe, et al.
Published: (2012-01-01)

Predictors of switching antipsychotic medications in the treatment of schizophrenia
by: Stauffer Virginia L, et al.
Published: (2010-09-01)

THE ROLE OF ATYPICAL ANTIPSYCHOTIC DECREASING AGGRESIVENESS IN SCHIZOPHRENIA
by: Juvita Novia Anggraini Maria
Published: (2013-03-01)

Atypical antipsychotics in the treatment of early-onset schizophrenia
by: Hrdlicka M, et al.
Published: (2015-04-01)

Oculomotor and neuropsychological effects of antipsychotic treatment for schizophrenia
by: Kristian S. Hill, et al.
Published: (2009-04-01)

Regional brain metabolism in schizophrenia: The influence of antipsychotics
by: Seethalakshmi R, et al.
Published: (2007-01-01)

The Study of Antipsychotic-induced Osteoporosis in Inpatients with Schizophrenia
by: Ping-Wing Lui, et al.
Published: (2009)

Current Status and Future Opportunities of Omics Tools in Mycotoxin Research
by: Manal Eshelli, et al.
Published: (2018-10-01)

Hunting for molecules in schizophrenia through omics technologies
by: Ceren Acar
Published: (2020-03-01)

Prioritization of schizophrenia risk genes from GWAS results by integrating multi-omics data
by: Dan He, et al.
Published: (2021-03-01)

The effects of antipsychotic drugs on depression level in patients with schizophrenia: clozapine vs. other atypical antipsychotics
by: Burkay Yakar, et al.
Published: (2016-08-01)

Acute myeloid leukemia: current progress and future directions
by: Hagop Kantarjian, et al.
Published: (2021-02-01)

Trends in Antipsychotic Use of Newly Treated Schizophrenia Patients
by: Yun-Ning Tseng, et al.
Published: (2018)

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-08-01)

Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia
by: Verónica Gamón, et al.
Published: (2021-06-01)

Antipsychotic Effects on Cortical Morphology in Schizophrenia and Bipolar Disorders
by: Ruiqi Feng, et al.
Published: (2020-12-01)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
by: Davide Amato, et al.
Published: (2019-05-01)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
by: Eduard Parellada, et al.
Published: (2012-01-01)

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
by: Nyhuis Allen W, et al.
Published: (2009-09-01)

Working memory and Parkinsonism due to antipsychotic medications in Schizophrenia
by: Amir eSalem, et al.
Published: (2015-05-01)

Cannot write session to /tmp/vufind_sessions/sess_is3a9g9bj0niu39mpr9eekfbqe